Sign in

CIK 0001023024

  • Large accelerated filer

ANI PHARMACEUTICALS INC

Sign in to watch
Ticker
ANIP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
582301143
Phone
+1 609-759-1810
Business address
104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
Former names
BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,975,156
in 10 filings, $2.0M under 10b5-1 plans

Net −$1,975,156. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-03-19 PRZYBYL ARTHUR President and CEO Sale −2,823 $63.51 $179K 205,076
2019-03-19 PRZYBYL ARTHUR President and CEO Exercise or conversion · Stock Options −2,823 35,625
2019-03-18 PRZYBYL ARTHUR President and CEO Sale −24,802 $63.53 $1.6M 205,076
2019-03-18 PRZYBYL ARTHUR President and CEO Exercise or conversion · Stock Options −6,375 0
2019-03-18 PRZYBYL ARTHUR President and CEO Exercise or conversion · Stock Options −9,375 18,750
2019-03-18 PRZYBYL ARTHUR President and CEO Exercise or conversion · Stock Options −9,052 38,448
2019-03-13 Schrepfer Robert W SVP - New Bus Dev & Spec Sales Exercise or conversion +4,651 $33.00 $153K 52,493
2019-03-13 Schrepfer Robert W SVP - New Bus Dev & Spec Sales Sale −4,651 $64.43 $300K 47,842
2019-03-13 Schrepfer Robert W SVP - New Bus Dev & Spec Sales Exercise or conversion · Option to Purchase −4,651 3,846
2019-03-12 Schrepfer Robert W SVP - New Bus Dev & Spec Sales Exercise or conversion +5,642 $28.76 $162K 53,484
2019-03-12 Schrepfer Robert W SVP - New Bus Dev & Spec Sales Sale −5,642 $64.44 $364K 47,842
2019-03-12 Schrepfer Robert W SVP - New Bus Dev & Spec Sales Exercise or conversion +1,503 $33.00 $50K 49,345
2019-03-12 Schrepfer Robert W SVP - New Bus Dev & Spec Sales Sale −1,503 $64.50 $97K 47,842
2019-03-12 Schrepfer Robert W SVP - New Bus Dev & Spec Sales Exercise or conversion · Option to Purchase −5,642 608
2019-03-12 Schrepfer Robert W SVP - New Bus Dev & Spec Sales Exercise or conversion · Option to Purchase −1,503 8,497
2018-09-11 Schrepfer Robert W SVP - New Bus Dev & Spec Sales Exercise or conversion +28,688 $6.60 $189K 47,842
2018-09-11 Schrepfer Robert W SVP - New Bus Dev & Spec Sales Exercise or conversion · Option to Purchase −28,688 0
2018-06-06 Walsh Patrick D Director Grant or award +1,800 1,800
2018-06-06 Walsh Patrick D Director Grant or award · Stock Options +2,225 2,225
2018-06-06 NASH DAVID Director Grant or award +1,800 1,800

Page 30 of 31 · 601 trades